SCHEMBL17097638

SCHEMBL17097638

CCOC(=O)[C@H]1CC[C@H](n2ncc(C(=O)N(CC(=O)c3c(O)cccc3Cl)Cc3cc(F)cc(F)c3)c2C(F)(F)F)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.34
TP53 P04637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
TSHR P16473 3/20 0.34
KDM4E B2RXH2 3/20 0.34
NR1H4 Q96RI1 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
HSD11B1 P28845 1/20 0.33
CCR2 P41597 2/20 0.32
KCNH2 Q12809 2/20 0.32
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
GAA P10253 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17097642 1.00 POLB (0.34) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17099181 0.93 HSD11B1 (0.35) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17099183 0.93 HSD11B1 (0.35) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17097625 0.92 EGFR (0.34) POLBTP53TDP1KDM4ENR1H4
SCHEMBL17097522 0.92 POLB (0.35) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17097627 0.92 EGFR (0.34) POLBTP53TDP1KDM4ENR1H4
SCHEMBL17097524 0.92 POLB (0.35) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17097775 0.91 ALDH1A1 (0.37) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17097778 0.91 ALDH1A1 (0.37) POLBTP53TDP1SMN1; SMN2TSHR
SCHEMBL17098811 0.90 VCAM1 (0.37) POLBTP53TDP1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA POLB 4102/4885TP53 1806/4885TDP1 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.